Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma is a research paper published in Nature Cancer (2025). On theSindex it has a DataRank of 0.456. It has been cited 13 times, with 12 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.0599
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 12 citers.
Austrian Science Fund (FWF)
Grant: I 4677
Complex biomaterials: engineering mimetic epithelial tissue
Austrian Science Fund (FWF)
Grant: I 3522
The role of activin signaling in small cell lung cancer
Austrian Science Fund (FWF)
Grant: I 3977
Vessel cooption in malignant pleural mesothelioma
Wellcome Trust
Grant: 220589
Investigating the contribution of gamma-delta T-cells to immunosurveillance of cancer and response to immunotherapy
FWCI
10.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals